Title | Type | SJR | H index | Total Docs. (2023) | Total Docs. (3years) | Total Refs. (2023) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2023) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
51 | Cancer Reports | journal | 0.571 Q3 | 18 | 233 | 424 | 10378 | 804 | 417 | 1.89 | 44.54 | |
52 | Epigenomics | journal | 0.751 Q3 | 77 | 100 | 420 | 6506 | 1140 | 390 | 2.27 | 65.06 | |
53 | Leukemia Research | journal | 0.694 Q3 | 96 | 123 | 405 | 3859 | 707 | 281 | 1.61 | 31.37 | |
54 | Cancer Biomarkers | journal | 0.579 Q3 | 54 | 84 | 404 | 3243 | 958 | 401 | 2.13 | 38.61 | |
55 | Biochimica et Biophysica Acta - Reviews on Cancer | journal | 2.838 Q1 | 159 | 155 | 390 | 26605 | 4360 | 387 | 10.09 | 171.65 | |
56 | Cancer Causes and Control | journal | 0.934 Q2 | 147 | 149 | 381 | 5689 | 878 | 369 | 2.24 | 38.18 | |
57 | Journal of Oral Pathology and Medicine | journal | 0.716 Q3 | 95 | 126 | 378 | 3699 | 1144 | 365 | 3.22 | 29.36 | |
58 | Cancer Gene Therapy | journal | 1.457 Q2 | 99 | 165 | 367 | 9395 | 1780 | 354 | 4.96 | 56.94 | |
59 | Prostate Cancer and Prostatic Diseases | journal | 1.711 Q1 | 78 | 199 | 355 | 6017 | 1550 | 312 | 4.15 | 30.24 | |
60 | Hematological Oncology | journal | 0.820 Q2 | 54 | 143 | 344 | 5325 | 778 | 271 | 2.29 | 37.24 | |
61 | Breast Cancer Research | journal | 2.578 Q1 | 175 | 147 | 340 | 7128 | 2515 | 334 | 5.80 | 48.49 | |
62 | Nature Reviews Cancer | journal | 26.837 Q1 | 505 | 105 | 304 | 10805 | 10951 | 163 | 31.23 | 102.90 | |
63 | Cancer Communications | journal | 4.950 Q1 | 79 | 108 | 289 | 4873 | 3552 | 176 | 12.39 | 45.12 | |
64 | Tumori | journal | 0.466 Q4 | 59 | 85 | 288 | 2531 | 402 | 270 | 1.45 | 29.78 | |
65 | Oncology Research and Treatment | journal | 0.521 Q3 | 55 | 67 | 283 | 2025 | 448 | 264 | 1.41 | 30.22 | |
66 | Endocrine-Related Cancer | journal | 1.331 Q2 | 146 | 108 | 282 | 6365 | 1135 | 275 | 4.11 | 58.94 | |
67 | Oncology | journal | 0.832 Q2 | 107 | 85 | 276 | 2687 | 771 | 270 | 2.50 | 31.61 | |
68 | International Journal of Cancer Management | journal | 0.198 Q4 | 26 | 61 | 254 | 1829 | 142 | 247 | 0.54 | 29.98 | |
69 | Cellular oncology (Dordrecht) | journal | 1.489 Q2 | 58 | 147 | 252 | 9711 | 1445 | 250 | 5.11 | 66.06 | |
70 | Molecular and Cellular Oncology | journal | 0.471 Q3 | 37 | 4 | 244 | 155 | 237 | 156 | 0.88 | 38.75 | |
71 | Discover Oncology | journal | 0.715 Q3 | 44 | 230 | 228 | 12219 | 609 | 225 | 2.72 | 53.13 | |
72 | npj Precision Oncology | journal | 2.871 Q1 | 36 | 134 | 227 | 7435 | 1667 | 224 | 6.48 | 55.49 | |
73 | Cancer and Metastasis Reviews | journal | 2.866 Q1 | 167 | 85 | 214 | 14862 | 1880 | 192 | 6.96 | 174.85 | |
74 | FASEB BioAdvances | journal | 0.764 Q3 | 18 | 40 | 210 | 1940 | 560 | 202 | 2.52 | 48.50 | |
75 | Targeted Oncology | journal | 1.421 Q2 | 59 | 80 | 206 | 3070 | 815 | 200 | 3.84 | 38.38 | |
76 | Experimental Hematology and Oncology | journal | 2.384 Q1 | 42 | 103 | 201 | 7008 | 1426 | 145 | 6.15 | 68.04 | |
77 | Infectious Agents and Cancer | journal | 0.424 Q4 | 47 | 78 | 200 | 4349 | 636 | 195 | 3.00 | 55.76 | |
78 | Cancer Genomics and Proteomics | journal | 0.722 Q3 | 50 | 65 | 197 | 4039 | 516 | 197 | 2.80 | 62.14 | |
79 | Apoptosis : an international journal on programmed cell death | journal | 1.427 Q2 | 128 | 111 | 193 | 7674 | 1133 | 179 | 6.12 | 69.14 | |
80 | Clinical and Experimental Metastasis | journal | 1.216 Q2 | 109 | 54 | 188 | 3077 | 711 | 171 | 3.99 | 56.98 | |
81 | Function | journal | 0.987 Q2 | 16 | 74 | 173 | 3180 | 401 | 136 | 2.18 | 42.97 | |
82 | South Asian Journal of Cancer | journal | 0.222 Q4 | 25 | 122 | 161 | 2596 | 103 | 134 | 0.55 | 21.28 | |
83 | Angiogenesis | journal | 3.289 Q1 | 101 | 41 | 153 | 2275 | 1284 | 128 | 8.13 | 55.49 | |
84 | Breast Disease | journal | 0.361 Q4 | 36 | 52 | 148 | 1503 | 174 | 148 | 0.91 | 28.90 | |
85 | Gaceta Mexicana de Oncologia | journal | 0.105 Q4 | 7 | 56 | 143 | 1473 | 20 | 132 | 0.18 | 26.30 | |
86 | Familial Cancer | journal | 1.016 Q2 | 67 | 54 | 138 | 1749 | 305 | 131 | 2.28 | 32.39 | |
87 | NAR Cancer | journal | 2.127 Q1 | 17 | 62 | 133 | 4757 | 556 | 132 | 3.40 | 76.73 | |
88 | International Journal of Biological Markers | journal | 0.528 Q3 | 47 | 27 | 126 | 1051 | 263 | 126 | 2.14 | 38.93 | |
89 | Advances in Biological Regulation | journal | 1.114 Q2 | 69 | 39 | 111 | 2651 | 395 | 105 | 2.77 | 67.97 | |
90 | Differentiation | journal | 0.619 Q3 | 107 | 50 | 96 | 3894 | 212 | 93 | 2.17 | 77.88 | |
91 | Atlas of Genetics and Cytogenetics in Oncology and Haematology | journal | 0.153 Q4 | 4 | 0 | 80 | 0 | 26 | 80 | 0.00 | 0.00 | |
92 | Cancer Treatment and Research | journal | 0.133 Q4 | 65 | 97 | 69 | 7075 | 69 | 1 | 0.63 | 72.94 | |
93 | Cell Stress | journal | 1.852 Q1 | 27 | 12 | 67 | 632 | 350 | 67 | 3.53 | 52.67 | |
94 | Oncology Reviews | journal | 0.747 Q3 | 31 | 16 | 49 | 1257 | 158 | 48 | 2.67 | 78.56 | |
95 | Tumour Virus Research | journal | 0.904 Q2 | 34 | 17 | 49 | 1333 | 208 | 47 | 4.94 | 78.41 | |
96 | European Journal of Cancer, Supplement | journal | 0.759 Q3 | 29 | 0 | 14 | 0 | 31 | 13 | 0.33 | 0.00 | |
97 | IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer | book series | 0.133 Q4 | 50 | 4 | 1 | 194 | 0 | 1 | 0.00 | 48.50 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®